REFERENCES

1. Marras C, Beck JC, Bower JH, et al. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis 2018;4:21.

2. Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA 2020;323:548-60.

3. Weintraub D. Management of psychiatric disorders in Parkinson’s disease: Neurotherapeutics - Movement disorders therapeutics. Neurotherapeutics 2020;17:1511-24.

4. Yamanishi T, Tachibana H, Oguru M, et al. Anxiety and depression in patients with Parkinson’s disease. Intern Med 2013;52:539-45.

5. Dissanayaka NNW, White E, O’Sullivan JD, et al. Characteristics and treatment of anxiety disorders in Parkinson’s disease. Mov Disord Clin Pract 2015;2:155-62.

6. Broen MPG, Köhler S, Moonen AJH, et al. Modeling anxiety in Parkinson’s disease. Mov Disord 2016;31:310-6.

7. Szatmari S, Illigens BMW, Siepmann T, Pinter A, Takats A, Bereczki D. Neuropsychiatric symptoms in untreated Parkinson’s disease. Neuropsychiatr Dis Treat 2017;13:815-26.

8. Sagna A, Gallo JJ, Pontone GM. Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease. Parkinsonism Relat Disord 2014;20:708-15.

9. Landers MR, Jacobson KM, Matsunami NE, McCarl HE, Regis MT, Longhurst JK. A vicious cycle of fear of falling avoidance behavior in Parkinson’s disease: a path analysis. Clin Park Relat Disord 2021;4:100089.

10. Spielberger C, Gorsuch R, Lushene R. Manual for the State-Trait Anxiety Inventory. 1970. Available from: https://www.semanticscholar.org/paper/Manual-for-the-State-Trait-Anxiety-Inventory-Spielberger-Gorsuch/e6d09d04fc8737094c193da471e2a50a809f77d4. [Last accessed on 25 Jan 2024].

11. Spielberger CD. Chapter 1 - Theory and research on anxiety. In: Spielberger CD, editor. Anxiety and Behavior. New York: Academic Press; 1966. pp.3-20.

12. Broen MPG, Leentjens AFG, Hinkle JT, et al. Clinical markers of anxiety subtypes in Parkinson disease. J Geriatr Psychiatry Neurol 2018;31:55-62.

13. Weintraub D, Simuni T, Caspell-Garcia C, et al. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson’s disease. Mov Disord 2015;30:919-27.

14. Miller JB, Cummings J, Nance C, Ritter A. Neuroscience learning from longitudinal cohort studies of Alzheimer’s disease: lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience. Alzheimers Dement 2018;4:350-6.

15. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.

16. Marek K, Jennings D, Lasch S, et al. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 2011;95:629-35.

17. Yesavage JA, Sheikh JI. 9/Geriatric Depression Scale (GDS). Clin Gerontol 1986;5:165-73.

18. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-70.

19. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-9.

20. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2020. Available from: https://www.r-project.org/index.html. [Last accessed on 25 Jan 2024].

21. Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. J Open Source Softw 2019;4:1686.

22. Yoshida K, Bartel A, Chipman JJ, et al. Tableone: Create ‘Table 1’ to describe baseline characteristics with or without propensity score weights. Available from: https://rdrr.io/cran/tableone/. [Last accessed on 25 Jan 2024].

23. DeMarco EC, Zhang Z, Al-Hakeem H, Hinyard L. Depression after Parkinson’s disease: treated differently or not at all? J Geriatr Psychiatry Neurol 2023;36:39-51.

24. National Institute of Mental Health. Any anxiety disorder. 2017. Available from: https://www.nimh.nih.gov/health/statistics/any-anxiety-disorder. [Last accessed on 25 Jan 2024].

25. Landau S, Harris V, Burn DJ, et al. Anxiety and anxious-depression in Parkinson’s disease over a 4-year period: a latent transition analysis. Psychol Med 2016;46:657-67.

26. Knowles KA, Olatunji BO. Specificity of trait anxiety in anxiety and depression: meta-analysis of the State-Trait Anxiety Inventory. Clin Psychol Rev 2020;82:101928.

27. Forrest SJ, Siegert RJ, Krägeloh CU, Landon J, Medvedev ON. Generalizability theory distinguishes between state and trait anxiety. Psychol Assess 2021;33:1080-8.

28. van der Velden RMJ, Broen MPG, Kuijf ML, Leentjens AFG. Frequency of mood and anxiety fluctuations in Parkinson’s disease patients with motor fluctuations: a systematic review. Mov Disord 2018;33:1521-7.

29. He L, Lee EY, Sterling NW, et al. The key determinants to quality of life in Parkinson’s disease patients: results from the Parkinson’s Disease Biomarker Program (PDBP). J Parkinsons Dis 2016;6:523-32.